Physician profile
William E Putman
NPI 1245226778
$6,425.92
in general payments reported to CMS, 2019-2025
20 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $733 · 2020: $125 · 2021: $1,032 · 2022: $2,275 · 2023: $1,446 · 2024: $574 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,260.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,211.29 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $639.56 | 2021-2022 | |
| Amarin Pharma, INC. | $497.37 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $492.88 | 2022-2023 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $398.70 | 2020-2023 | Austedo Xr |
| Kyowa Kirin, INC. | $249.53 | 2022-2023 | Nourianz |
| Astrazeneca Pharmaceuticals LP | $248.56 | 2021-2025 | Breztri |
| E.R. Squibb & Sons, L.L.C. | $245.09 | 2022-2024 | Zeposia |
| Emd Serono, INC. | $228.52 | 2021-2022 | |
| Esperion Therapeutics, INC. | $150.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2019 | |
| Tg Therapeutics, INC. | $124.84 | 2023 | |
| Horizon Therapeutics Plc | $124.84 | 2022 | |
| Banner Life Sciences, LLC | $124.83 | 2022 | |
| Axsome Therapeutics, INC. | $123.53 | 2024 | Auvelity |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $120.00 | 2022 | |
| Urovant Sciences INC | $116.55 | 2022 | |
| Janssen Pharmaceuticals, INC | $110.93 | 2019 | |
| Acadia Pharmaceuticals INC | $72.45 | 2021-2024 | Nuplazid |
| Vanda Pharmaceuticals INC. | $21.45 | 2024 | Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Putman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.